Structural and functional analysis of cyclin D1 reveals p27 and substrate inhibitor binding requirements.
Ontology highlight
ABSTRACT: An alternative strategy for inhibition of the cyclin dependent kinases (CDKs) in antitumor drug discovery is afforded through the substrate recruitment site on the cyclin positive regulatory subunit. Critical CDK substrates such as the Rb and E2F families must undergo cyclin groove binding before phosphorylation, and hence inhibitors of this interaction also block substrate specific kinase activity. This approach offers the potential to generate highly selective and cell cycle specific CDK inhibitors and to reduce the inhibition of transcription mediated through CDK7 and 9, commonly observed with ATP competitive compounds. While highly potent peptide and small molecule inhibitors of CDK2/cyclin A, E substrate recruitment have been reported, little information has been generated on the dete
SUBMITTER: Liu S
PROVIDER: S-EPMC3425359 | biostudies-literature | 2010 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA